Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: South Korea Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20152
20161
20182
20192
20202
20234
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8
Completed5
Active, not recruiting4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Regeneron Pharmaceuticals2
Sanofi2
Shaperon2
AbbVie1
Amgen1
Amorepacific Corporation1
AstraZeneca1
EHL Bio Co., Ltd.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic19
Dermatitis4
Eczema4
Immune System Diseases2
Lymphoma, Follicular2
Inflammation1
Pruritus1
Skin Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.